What is the difference between omega-3 triglyceride and ethyl ester forms?

TG form has better bioavailability and is more natural. EE form is easier to concentrate to >90% EPA+DHA by fractional distillation. Prescription omega-3 drugs use EE form. Lipase with glycerol converts EE back to rTG if needed.

Omega-3 Concentration Process — EPA/DHA from Fish Oil and Algae

Q: Why do polyunsaturated fatty acids not form urea inclusion complexes?

EPA and DHA have 5-6 cis double bonds creating pronounced chain kinks that cannot fit into the cylindrical hexagonal urea lattice channels. Saturated and mono-unsaturated fatty acids with linear geometry do form complexes, enabling the separation.

Q: What is molecular distillation and why is it needed for omega-3 concentration?

Molecular distillation operates at 0.001-0.01 mbar where mean free path exceeds evaporator-condenser distance. Fatty acids distill at 120-180 degrees C instead of >300 degrees C, avoiding oxidative degradation while separating by MW and vapor pressure.

Q: How is algae-derived DHA different from fish oil DHA in processing?

Microalgae produce 40-50% DHA with little EPA, unlike fish oil containing both. Algae oil is cleaner with lower pigment load. Processing is similar but activated charcoal is often omitted. Preferred source for infant formula DHA.

Process Overview

EPA (eicosapentaenoic acid, C20:5n-3) and DHA (docosahexaenoic acid, C22:6n-3) are the biologically active omega-3 fatty acids linked to cardiovascular, neurological, and anti-inflammatory health benefits. Crude fish oil typically contains 25–35% EPA+DHA as triglycerides; microalgae oil contains 40–50% DHA. Pharmaceutical and nutraceutical applications require >85% EPA+DHA. The concentration process combines chemical saponification, selective inclusion complex formation with urea, high-vacuum molecular distillation, and enzymatic re-esterification.

30% → >85%

EPA+DHA Concentration

>85%

Final EPA+DHA

6

Unit Operations

Ethyl ester

Product Form

Process Steps

1

Chemical Reaction

Saponification (KOH/Ethanol, 70°C)

React fish oil or algae oil with KOH in ethanol (0.5 M KOH, 50% EtOH v/v) at 70°C for 1 hour under nitrogen atmosphere. Saponification converts triglycerides to free fatty acids (as potassium soaps) and glycerol. All fatty acids are liberated as their potassium salts: EPA-K⁺, DHA-K⁺, palmitate-K⁺, oleate-K⁺. This step is the prerequisite for urea complexation, which requires free fatty acids.

Conversion: >99%

EPA+DHA: ~30% (unchanged)

2

Selective Complexation

Urea Complexation (4°C)

Dissolve urea in hot ethanol (5:1 w/w urea:fatty acid), mix with the saponified fatty acids, and cool to 4°C over 4–8 hours. Saturated and mono-unsaturated fatty acids (palmitic, stearic, oleic) readily form solid inclusion clathrates with urea in a hexagonal lattice. Polyunsaturated EPA and DHA (multiple cis double bonds → kinked chain geometry) do NOT fit into the urea lattice and remain in the liquid phase. Filter to separate solid urea complexes (saturates) from liquid-phase EPA/DHA-rich fraction.

EPA+DHA enrichment: 30% → 60–70%

Recovery: 85–90%

3

Solid–Liquid Separation

Filtration — Remove Urea Complexes

Filter the cold mixture through a vacuum or pressure filter to collect the solid urea clathrates (containing saturated fatty acids) and separate the filtrate (EPA/DHA-rich liquid phase). Wash the filter cake with cold ethanol to recover entrained EPA/DHA. The filtrate contains the concentrated omega-3 fraction as free fatty acid potassium salts in ethanol/water. Urea recovered from the filter cake by hot-water dissolution and recrystallization for reuse.

EPA+DHA: 60–70%

Yield: >85%

4

Acidification

Acidification with H₂SO₄ to pH 4

Add dilute sulfuric acid to the filtrate to reduce pH to 3–4, converting potassium fatty acid salts to free fatty acids (FFA). The FFA layer separates from the aqueous ethanol phase as an oil. Decant or centrifuge to recover the FFA-rich oil phase. Wash with water (2–3 ×) to remove residual urea and ethanol. The recovered oil contains 60–70% EPA+DHA as free fatty acids, suitable for molecular distillation.

Yield: >95%

Form: Free fatty acids

5

High-Vacuum Distillation

Molecular Distillation (120–180°C, 0.001 mbar)

Distill the FFA mixture in a molecular (short-path) distillation unit at 0.001 mbar (1 Pa) and 120–180°C evaporator temperature. Under these conditions, the mean free path of vapor molecules exceeds the evaporator-condenser distance (1–5 cm), enabling gentle distillation below the normal boiling points. EPA (C20:5) and DHA (C22:6) distill selectively; shorter-chain, more volatile fatty acids distill at lower temperatures. Heavy residues (sterols, tocopherols) remain in the residue. Multiple distillation passes increase EPA+DHA to >85%.

EPA+DHA: >85%

Yield: 75–85%

6

Enzymatic Reaction

Re-esterification to Ethyl Esters (Lipase Catalysis)

React concentrated FFA with anhydrous ethanol (1:5 molar ratio FFA:EtOH) using an immobilized lipase catalyst (e.g., Candida antarctica lipase B, Novozyme 435) at 40°C for 6–12 hours under reduced pressure to remove water. Conversion >95%. Ethyl esters (EE) are preferred over triglycerides for pharmaceutical omega-3 products (e.g., Vascepa, Lovaza) because EE form is more readily concentrated and has better bioavailability in some formulations. Remove ethanol by evaporation and wash product to yield the final omega-3 EE concentrate.

Conversion: >95%

Form: Ethyl esters >85% EPA+DHA

Key Fatty Acids: EPA and DHA

EPA (Eicosapentaenoic acid)	C20:5n-3, MW 302 Da, 5 cis double bonds, melting point −54°C
DHA (Docosahexaenoic acid)	C22:6n-3, MW 328 Da, 6 cis double bonds, melting point −44°C
Urea complexation selectivity	Saturates form clathrates; PUFA (EPA/DHA) do not due to kinked chain geometry
Oxidative stability	Highly susceptible to autoxidation; process under N₂ or Ar, add antioxidant (tocopherol)
Sources	Anchovy, sardine, menhaden oil (30–35% EPA+DHA); microalgae Thraustochytrid (50% DHA)
Regulatory	GRAS, FDA-approved (Vascepa: 96% EPA EE; Lovaza: 84% EPA+DHA EE)

Cost Considerations

Step	Key Cost Driver	Relative Cost
Saponification	KOH, ethanol, reactor vessel	Low
Urea Complexation	Urea (recyclable), refrigeration energy	Medium
Filtration	Filter membranes, wash ethanol	Low
Molecular Distillation	High-vacuum equipment capital, energy, multiple passes	High
Re-esterification	Novozyme 435 lipase (recyclable), ethanol	Medium

Molecular distillation equipment is the capital cost bottleneck. Short-path distillation units capable of handling viscous fatty acid mixtures at high vacuum cost $0.5–2M per unit. Multiple distillation passes may be needed for pharmaceutical-grade (>96% EPA). Urea is recyclable, reducing operating cost significantly. Lipase catalysts (Novozyme 435) are reusable for 100–200 batch cycles. Use untangle.bio to model your omega-3 process economics.

Frequently Asked Questions

Why do polyunsaturated fatty acids not form urea inclusion complexes?

Urea crystallizes in a hexagonal lattice with cylindrical channels that accommodate straight-chain molecules. Saturated and mono-unsaturated fatty acids (with largely linear chain geometry) fit into these channels and form stable inclusion complexes. EPA and DHA have 5–6 cis double bonds that create pronounced kinks in the carbon chain, making the molecule too bent to fit into the urea channel geometry. This physical selectivity provides the basis for the separation without any chemical modification of the fatty acids.

What is molecular distillation and why is it needed for omega-3 concentration?

Molecular distillation (short-path distillation) operates at pressures of 0.001–0.01 mbar, where the mean free path of vapor molecules (~1–5 cm) exceeds the evaporator-to-condenser distance. This allows fatty acids to distill at 120–180°C rather than their atmospheric boiling points (>300°C). At atmospheric pressure, fatty acids would oxidize and degrade before distilling. The technique separates fatty acids by molecular weight and vapor pressure differences, providing the final enrichment step to >85% EPA+DHA.

What is the difference between omega-3 triglyceride (TG) and ethyl ester (EE) forms?

TG form (re-esterified triglyceride, rTG) is more similar to natural fish oil and may have better bioavailability due to efficient pancreatic lipase hydrolysis. EE form (ethyl ester) is easier to concentrate to very high EPA+DHA (>90%) because EE can be efficiently fractionally distilled. Prescription omega-3 drugs (Vascepa, Lovaza) use the EE form. The rTG form is preferred for some consumer supplements. Lipase re-esterification with glycerol (instead of ethanol) converts EE back to rTG if required.

How is algae-derived DHA different from fish oil DHA in processing?

Microalgae (Thraustochytrid, Schizochytrium) produce oil with 40–50% DHA but little EPA, unlike fish oil which contains both. Algae oil is the preferred sustainable source for infant formula DHA (Martek/DSM). The downstream process is similar but saponification conditions may differ due to the triglyceride composition. Algae oil is generally cleaner (lower pigment load, no fishy odor precursors) so activated charcoal treatment is often omitted. Urea complexation selectively retains DHA in the non-complexed fraction.

Related Resources

Glycerol Properties Ethanol Properties Crystallization Spray Drying Bioethanol Production Process

Omega-3 Concentration Process